The use of fluorescence microscopy to study the association between herpesviruses and intrinsic resistance factors

Viruses

Volumn 3, Issue 12, 2011, Pages 2412-2424

  Everett, Roger D ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

Herpes Simplex Virus type 1; ICPO; Intrinsic antiviral resistance; ND10; PML nuclear bodies; SUMO

Indexed keywords

CELL PROTEIN; DEOXYRIBONUCLEOPROTEIN; NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN ICP0; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL RESISTANCE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CELL STRUCTURE; DNA DAMAGE; DNA REPAIR; DNA VIRUS; FLUORESCENCE MICROSCOPY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; NONHUMAN; NUCLEAR DOMAIN 10; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; DNA REPAIR; GENOME, VIRAL; HERPESVIRIDAE; HERPESVIRUS 1, HUMAN; HUMANS; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VIRUS REPLICATION;

EID: 84255173377     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3122412     Document Type: Review

References (51)

1. Bieniasz, P.D. Intrinsic immunity: A front-line defense against viral attack. Nat. Immunol. 2004, 5, 1109-1115
2. Tavalai, N.; Stamminger, T. New insights into the role of the subnuclear structure ND10 for viral infection. Biochim. Biophys. Acta 2008, 1783, 2207-2221.
3. Maul, G.G.; Guldner, H.H.; Spivack, J.G. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 1993, 74, 2679-2690.
4. Boutell, C.; Sadis, S.; Everett, R.D. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated ring finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 2002, 76, 841-850.
5. Everett, R.D.; Freemont, P.; Saitoh, H.; Dasso, M.; Orr, A.; Kathoria, M.; Parkinson, J. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 1998, 72, 6581-6591.
6. Everett, R.D.; Chelbi-Alix, M.K. Pml and pml nuclear bodies: Implications in antiviral defence. Biochimie 2007, 89, 819-830.
7. Everett, R.D. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 2001, 20, 7266-7273.
8. Cantrell, S.R.; Bresnahan, W.A. Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J. Virol. 2006, 80, 6188-6191.
9. Everett, R.D.; Rechter, S.; Papior, P.; Tavalai, N.; Stamminger, T.; Orr, A. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 2006, 80, 7995-8005.
10. Everett, R.D.; Parada, C.; Gripon, P.; Sirma, H.; Orr, A. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J. Virol. 2008, 82, 2661-2672.
11. Lukashchuk, V.; McFarlane, S.; Everett, R.D.; Preston, C.M. Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J. Virol. 2008, 82, 12543-12554.
12. Lukashchuk, V.; Orr, A.; Everett, R.D. Regulation of ICP0 null mutant HSV-1 infection by ND10 components ATRX and hDaxx. J. Virol. 2010, 84, 4026-4040.
13. Preston, C.M.; Nicholl, M.J. Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J. Gen. Virol. 2006, 87, 1113-1121.
14. Saffert, R.T.; Kalejta, R.F. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 2006, 80, 3863-3871.
15. Tavalai, N.; Papior, P.; Rechter, S.; Leis, M.; Stamminger, T. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J. Virol. 2006, 80, 8006-8018.
16. Tavalai, N.; Papior, P.; Rechter, S.; Stamminger, T. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J. Virol. 2008, 82, 126-137.
17. Tavalai, N.; Adler, M.; Scherer, M.; Riedl, Y. Stamminger, T. Evidence for a dual antiviral role of the major Nuclear Domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J. Virol. 2011, 85, 9447-9458.
18. Woodhall, D.L.; Groves, I.J.; Reeves, M.B.; Wilkinson, G.; Sinclair, J.H. Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J. Biol. Chem. 2006, 281, 37652-37660.
19. Kim, Y.E.; Lee, J.H.; Kim, E.T.; Shin, H.J.; Gu, S.Y.; Seol, H.S.; Ling, P.; Lee, C.H.; Ahn, J.H. Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J. Virol. 2011, doi:10.1128/JVI.00758-11.
20. Adler, M.; Tavalai, N.; Muller, R.; Stamminger, T. Human cytomegalovirus immediate-early gene expression is restricted by the Nuclear Domain 10 component Sp100. J. Gen. Virol. 2011, 92, 1532-1538.
21. Maul, G.G.; Ishov, A.M.; Everett, R.D. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 1996, 217, 67-75.
22. Ishov, A.M.; Maul, G.G. The periphery of nuclear domain 10 (ND10) as site of DNA virusdeposition. J. Cell Biol. 1996, 134, 815-826.
23. Maul, G.G. Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 1998, 20, 660-667.
24. Mohni, K.N.; Livingston, C.M.; Cortez, D.; Weller, S.K. ATR and ATRIP are recruited to herpes simplex virus type 1 replication compartments even though ATR signaling is disabled. J. Virol. 2010, 84, 12152-12164.
25. Wilcock, D.; Lane, D.P. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 1991, 349, 429-431.
26. Wilkinson, D.E.; Weller, S.K. Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response J. Virol. 2004, 78, 4783-4796.
27. Everett, R.D.; Sourvinos, G.; Leiper, C.; Clements, J.B.; Orr, A. Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: Localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. J. Virol. 2004, 78, 1903-1917.
28. DiDonato, J.A.; Spitzner, J.R.; Muller, M.T. A predictive model for DNA recognition by the herpes simplex virus protein ICP4. J. Mol. Biol. 1991, 219, 451-470.
29. Faber, S.W.; Wilcox, K.W. Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences in DNA. Nucleic Acids Res. 1986, 14, 6067-6083.
30. Knipe, D.M.; Senechek, D.; Rice, S.A.; Smith, J.L. Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4. J. Virol. 1987, 61, 276-284.
31. Randall, R.E.; Dinwoodie, N. Intranuclear localization of herpes simplex virus immediate-early and delayed-early proteins: Evidence that ICP 4 is associated with progeny virus DNA. J. Gen. Virol. 1986, 67, 2163-2177.
32. Everett, R.D.; Murray, J. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 2005, 79, 5078-5089.
33. Dohner, K.; Wolfstein, A.; Prank, U.; Echeverri, C.; Dujardin, D.; Vallee, R.; Sodeik, B. Function of dynein and dynactin in herpes simplex virus capsid transport. Mol. Biol. Cell 2002, 13, 2795-2809.
34. Sodeik, B.; Ebersold, M.W.; Helenius, A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 1997, 136, 1007-1021.
35. Everett, R.D.; Boutell, C.; Orr, A. Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J. Virol. 2004, 78, 1763-1774.
36. de Bruyn Kops, A.; Uprichard, S.L.; Chen, M.; Knipe, D.M. Comparison of the intranuclear distributions of herpes simplex virus proteins involved in various viral functions. Virology 1998, 252, 162-178.
37. Everett, R.D.; Sourvinos, G.; Orr, A. Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells. J. Virol. 2003, 77, 3680-3689.
38. Cuchet-Lourenco, D.; Boutell, C.; Lukashchuk, V.; Grant, K.; Sykes, A.; Murray, J.; Orr, A.; Everett, R.D. Sumo pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. PLoS Pathog. 2011, 7, e1002123.
39. Cuchet, D.; Sykes, A.K.; Nicolas, A.; Orr, A.; Murray, J.; Sirma, H.; Heeren, J.; Bartelt, A.; Everett, R.D. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J. Cell Sci. 2011, 124, 280-291.
40. Everett, R.D.; Murray, J.; Orr, A.; Preston, C.M. Herpes simplex virus type 1 genomes areassociated with ND10 nuclear substructures in quiescently infected human fibroblasts. J. Virol.2007, 81, 10991-11004.
41. Ishov, A.M.; Sotnikov, A.G.; Negorev, D.; Vladimirova, O.V.; Neff, N.; Kamitani, T.; Yeh, E.T.; Strauss, J.F.; Maul, G.G. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 1999, 147, 221-234.
42. Zhong, S.; Muller, S.; Ronchetti, S.; Freemont, P.S.; Dejean, A.; Pandolfi, P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood 2000, 95, 2748-2752.
43. Lukashchuk, V.; Everett, R.D. MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, U.K. Unpublished work.
44. Boutell, C.; Cuchet-Lourenco, D.; Vanni, E.; Glass, M.; McFarlane, S.; Orr, A.; Everett, R.D. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog. 2011, 7, e1002245.
45. Lilley, C.E.; Chaurushiya, M.S.; Boutell, C.; Everett, R.D.; Weitzman, M.D. The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0. PLoS Pathog. 2011, 7, e1002084.
46. Everett, R.D.; Parsy, M.L.; Orr, A. Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes. J. Virol. 2009, 83, 4963-4977.
47. Sourvinos, G.; Tavalai, N.; Berndt, A.; Spandidos, D.A.; Stamminger, T. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J. Virol. 2007, 81, 10123-10136.
48. Reichelt, M.; Brady, J.; Arvin, A.M. The replication cycle of varicella-zoster virus: Analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J. Virol. 2009, 83, 3904-3918.
49. Lilley, C.E.; Chaurushiya, M.S.; Boutell, C.; Landry, S.; Suh, J.; Panier, S.; Everett, R.D.; Stewart, G.S.; Durocher, D.; Weitzman, M.D. A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. EMBO J. 2010, 29, 943-955.
50. Galanty, Y.; Belotserkovskaya, R.; Coates, J.; Polo, S.; Miller, K.M.; Jackson, S.P. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 2009, 462, 935-939.
51. Morris, J.R.; Boutell, C.; Keppler, M.; Densham, R.; Weekes, D.; Alamshah, A.; Butler, L.; Galanty, Y.; Pangon, L.; Kiuchi, T.;et al. The SUMO modification pathway is involved in the brca1 response to genotoxic stress. Nature 2009, 462, 886-890.